AVADEL PHARMACEUTICALS PLC Quarterly Costs and Expenses in USD from Q1 2011 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Avadel Pharmaceuticals Plc quarterly/annual Costs and Expenses history and growth rate from Q1 2011 to Q3 2023.
  • Avadel Pharmaceuticals Plc Costs and Expenses for the quarter ending September 30, 2023 was $42M, a 148% increase year-over-year.
  • Avadel Pharmaceuticals Plc Costs and Expenses for the twelve months ending September 30, 2023 was $144M, a 46.3% increase year-over-year.
  • Avadel Pharmaceuticals Plc annual Costs and Expenses for 2022 was $98.6M, a 15.2% increase from 2021.
  • Avadel Pharmaceuticals Plc annual Costs and Expenses for 2021 was $85.5M, a 418% increase from 2020.
  • Avadel Pharmaceuticals Plc annual Costs and Expenses for 2020 was $16.5M, a 80.2% decline from 2019.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $144M $42M +$25M +148% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $119M $51M +$21.1M +70.4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $98.2M $28.3M -$328K -1.15% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $98.6M $23M -$98K -0.42% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-29
Q3 2022 $98.7M $17M -$8.7M -33.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $107M $29.9M +$8M +36.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $99.4M $28.6M +$13.8M +93.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $85.5M $23.1M +$8.88M +62.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 $76.7M $25.7M +$12M +87.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $64.7M $21.9M +$52.1M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $12.6M $14.8M -$3.93M -21% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $16.5M $14.3M -$4.08M -22.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-16
Q3 2020 $20.6M $13.7M -$4.68M -25.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $25.3M -$30.2M -$52.2M -237% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $77.5M $18.7M -$5.86M -23.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $83.3M $18.3M -$78M -81% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-16
Q3 2019 $161M $18.4M -$15.5M -45.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $177M $22M -$10M -31.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $187M $24.6M -$21.3M -46.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $208M $96.3M +$57.5M +148% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-09
Q3 2018 $151M $33.9M +$20.4M +150% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $130M $32M +$19.8M +163% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $110M $45.9M +$26.8M +140% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $83.7M $38.8M +$12.8M +49.2% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-16
Q3 2017 $70.9M $13.6M -$34.7M -71.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 $106M $12.2M -$38.2M -75.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $144M $19.2M -$11.3M -37.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $155M $26M +$59.1M Oct 1, 2016 Dec 31, 2016 10-K 2019-03-15
Q3 2016 $96.2M $48.3M -$13.5M -21.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $110M $50.4M -$571K -1.12% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $110M $30.5M +$8M +35.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $102M -$33M -$65.3M -202% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-16
Q3 2015 $168M $61.8M +$38M +159% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $130M $51M +$27.3M +115% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 $102M $22.5M -$6.3M -21.9% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $109M $32.3M +$41.7M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-28
Q3 2014 $67M $23.8M +$11.5M +92.6% Jul 1, 2014 Sep 30, 2014 6-K 2014-11-17
Q2 2014 $55.5M $23.7M -$16.2M -40.6% Apr 1, 2014 Jun 30, 2014 6-K 2015-12-31
Q1 2014 $71.7M $28.8M +$13.8M +92.2% Jan 1, 2014 Mar 31, 2014 6-K 2015-07-10
Q4 2013 $57.9M -$9.41M +$4.82M +33.9% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-15
Q3 2013 $53.1M $12.4M +$471K +3.95% Jul 1, 2013 Sep 30, 2013 6-K 2014-11-17
Q2 2013 $52.6M $39.9M +$27.6M +223% Apr 1, 2013 Jun 30, 2013 6-K 2014-08-08
Q1 2013 $25M $15M +$7.59M +102% Jan 1, 2013 Mar 31, 2013 6-K 2014-07-08
Q4 2012 $17.4M -$14.2M Oct 1, 2012 Dec 31, 2012 20-F/A 2015-10-01
Q3 2012 $11.9M Jul 1, 2012 Sep 30, 2012 6-K 2014-01-15
Q2 2012 $12.4M +$1.96M +18.8% Apr 1, 2012 Jun 30, 2012 6-K 2013-12-06
Q1 2012 $7.41M -$4.25M -36.5% Jan 1, 2012 Mar 31, 2012 6-K 2012-09-13
Q2 2011 $10.4M Apr 1, 2011 Jun 30, 2011 6-K 2012-12-14
Q1 2011 $11.7M Jan 1, 2011 Mar 31, 2011 6-K 2012-09-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.